SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-268926
Filing Date
2023-11-02
Accepted
2023-11-02 08:51:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d580756ddefa14a.htm DEFA14A 34032
2 GRAPHIC g580756g1102061912628.jpg GRAPHIC 2147
  Complete submission text file 0001193125-23-268926.txt   38474
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33004 | Film No.: 231370288
SIC: 2834 Pharmaceutical Preparations